The medicinal field has been making huge leaps in recent decades, and the healthcare industry is currently hungry for innovation.

Now, a Canadian healthcare company is looking to the future of life-saving genetic therapies, and you can take part.

Toronto-based Acorn Biolabs is offering people a more cost-effective way of collecting and storing their cells. Individual’s cells are being stored for future medical therapies and can be put to use in the future. The company has found a non-invasive method for preserving the genetic material found in the cells in human hair follicles. The process somewhat resembles a form of genetic insurance, as their workers can simply pluck a few hairs off your head, extract and analyze the cells, then store the cells at cryogenic temperatures.

The healthy, preserved cells can be accessed later and transformed into stem cells to treat disease. This form of “insurance” is something of a small gamble, as it relies on advancements in genetic therapy that haven’t been made yet, but which should be made before a young person today needs serious medical care. “Cell therapy is rapidly emerging as the future of healthcare,” said Acorn Biolabs CEO Drew Tailor, who believes “We need to work on banking our cells in advance so that when we are sick we have a source of cells that will drive the success of all of these potential therapies.”

Among several changes coming to the healthcare industry, regenerative medicine is currently seen as the next big thing. Researchers are currently studying how regenerative medicine can treat or prevent diseases like Parkinson’s, Alzheimer’s, and cancer.